![Takehiko Sawabe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Takehiko Sawabe
Director/Miembro de la Junta en Quantum Biosystems, Inc. .
Cargos activos de Takehiko Sawabe
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Quantum Biosystems, Inc.
![]() Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Director/Miembro de la Junta | - | - |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Director/Miembro de la Junta | - | - |
SCOHIA PHARMA, Inc.
![]() SCOHIA PHARMA, Inc. Miscellaneous Commercial ServicesCommercial Services SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe. | Director/Miembro de la Junta | - | - |
Historial de carrera de Takehiko Sawabe
Antiguos cargos conocidos de Takehiko Sawabe.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Megakaryon Corp.
![]() Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan. | Director/Miembro de la Junta | - | - |
Formación de Takehiko Sawabe.
University of Tokyo | Undergraduate Degree |
GLOBIS University | Masters Business Admin |
Estadísticas
Internacional
Japón | 7 |
Operativa
Director/Board Member | 4 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 4 |
---|---|
Quantum Biosystems, Inc.
![]() Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Health Technology |
Megakaryon Corp.
![]() Megakaryon Corp. Medical/Nursing ServicesHealth Services Megakaryon Corp. operates as an pluripotent stem cells research laboratory. It produce platelets and red blood cells from iPS cell lines, and to develop blood products that do not depend on blood donations. The firm specializes in development of technologies to produce and store induced pluripotent stem cell derived human T cells. Megakaryon was founded by Genjiro Miwa on September 9, 2011 and is headquartered in Kyoto, Japan. | Health Services |
Anaeropharma Science, Inc.
![]() Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
SCOHIA PHARMA, Inc.
![]() SCOHIA PHARMA, Inc. Miscellaneous Commercial ServicesCommercial Services SCOHIA PHARMA, Inc. is a drug discovery venture that focuses on lifestyle-related diseases. The company is based in Fujisawa, Japan. The Japanese company has a strong development pipeline and an experienced R & D team that specializes in drug discovery, including compound creation, drug efficacy evaluation, and clinical development. The CEO of the company is Masanori Watanabe. | Commercial Services |
- Bolsa de valores
- Insiders
- Takehiko Sawabe
- Experiencia